UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Sirolimus in Advanced Epithelioid Hemangioendothelioma: A Retrospective Case-Series Analysis from the Italian Rare Cancer Network Database

Annals of surgical oncology, 2016-09, Vol.23 (9), p.2735-2744

2016

Volltextzugriff (PDF)

Pazopanib in advanced and platinum-resistant urothelial cancer: an open-label, single group, phase 2 trial

The lancet oncology, 2012-08, Vol.13 (8), p.810-816

2012

Volltextzugriff (PDF)

Response to Sunitinib Malate in Advanced Alveolar Soft Part Sarcoma

Clinical cancer research, 2009-02, Vol.15 (3), p.1096-1104

2009

Volltextzugriff (PDF)

Neoadjuvant eribulin mesylate following anthracycline and taxane in triple negative breast cancer: Results from the HOPE study

PloS one, 2019-08, Vol.14 (8), p.e0220644-e0220644

2019

Volltextzugriff (PDF)

Simple preparation and purification of ethanol-free solutions of 3′-deoxy-3′-[18 F]fluorothymidine by means of disposable solid-phase extraction cartridges

Nuclear medicine and biology, 2012-05, Vol.39 (4), p.540-550

2012

Volltextzugriff (PDF)

Staging and follow-up of high-grade malignant salivary gland tumours: The role of traditional versus functional imaging approaches – A review

Oral oncology, 2016-09, Vol.60, p.157-166

2016

Volltextzugriff (PDF)

Interim Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography for Early Metabolic Assessment of Therapeutic Response to Chemotherapy for Metastatic Transitional Cell Carcinoma

Clinical genitourinary cancer, 2014-12, Vol.12 (6), p.433-439

2014

Volltextzugriff (PDF)

FDG-PET for axillary lymph node staging in primary breast cancer

European journal of nuclear medicine and molecular imaging, 2004-06, Vol.31 Suppl 1, p.S97-S102

2004

Volltextzugriff (PDF)

Amino acid positron emission tomography to monitor chemotherapy response and predict seizure control and progression-free survival in WHO grade II gliomas

Neuro-oncology (Charlottesville, Va.), 2016-05, Vol.18 (5), p.744-751

2016

Volltextzugriff (PDF)

Cabozantinib (CABO) plus durvalumab (DURVA) in patients with advanced and chemotherapy-treated bladder carcinoma of urothelial and non-urothelial histology: An open-label, single-arm, phase 2 trial

Journal of clinical oncology, 2018-02, Vol.36 (6_suppl), p.TPS536-TPS536

2018

Volltextzugriff (PDF)

F-FLT PET/CT as an imaging tool for early prediction of pathological response in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy: a pilot study

European journal of nuclear medicine and molecular imaging, 2015-05, Vol.42 (6), p.818-830

2015

Volltextzugriff (PDF)

Role of pretreatment 18F-FDG PET/CT parameters in predicting outcome of non-endemic EBV DNA-related nasopharyngeal cancer (NPC) patients treated with IMRT and chemotherapy

Radiologia medica, 2019-05, Vol.124 (5), p.414-421

2019

Volltextzugriff (PDF)

Pazopanib in patients (pts) with advanced germ cell tumors (GCT): Results from an open-label, single-group, phase 2 trial (Pazotest-01)

Journal of clinical oncology, 2016-01, Vol.34 (2_suppl), p.481-481

2016

Volltextzugriff (PDF)

Interim results from PURE-01: A phase 2, open-label study of neoadjuvant pembrolizumab (pembro) before radical cystectomy for muscle-invasive urothelial bladder carcinoma (MIUC)

Journal of clinical oncology, 2018-02, Vol.36 (6_suppl), p.TPS533-TPS533

2018

Volltextzugriff (PDF)

Imatinib mesylate in chordoma

Cancer, 2004-11, Vol.101 (9), p.2086-2097

2004

Volltextzugriff (PDF)

FDG-PET in thyroid cancer

Tumori, 2003-09, Vol.89 (5), p.540-543

2003

Volltextzugriff (PDF)

Design of an open label, randomized, phase II study of paclitaxel and panitumumab compared to paclitaxel alone in patients with relapsed or refractory urothelial cancer

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.TPS4570-TPS4570

2015

Volltextzugriff (PDF)

High efficiency preparation of L-[S-methyl-11C]methionine by on-column [11C]methylation on C18 Sep-Pak

Journal of labelled compounds & radiopharmaceuticals, 1999-08, Vol.42 (8), p.715-724

1999

Volltextzugriff (PDF)

Pan-HER tyrosine-kinase inhibitors (TKI) dacomitinib and afatinib in penile squamous cell carcinoma (PSCC): Results from an ongoing open-label, single-group, phase 2 trial of dacomitinib in chemonaive patients (pts)

Journal of clinical oncology, 2016-01, Vol.34 (2_suppl), p.483-483

2016

Volltextzugriff (PDF)

Pazopanib (PZP) in germ cell tumors (GCT) after chemotherapy (CT) failure: Final results of the open label, single-group, phase II Pazotest trial

Journal of clinical oncology, 2017-02, Vol.35 (6_suppl), p.414-414

2017

Volltextzugriff (PDF)

Nuclear medicine imaging in breast cancer: current strategies and future directions

Oncology (Williston Park, N.Y.), 2009-03, Vol.23 (3), p.269-270

2009

Volltextzugriff (PDF)

IMMUNO-PET: A NEW TOOL FOR PROSTATE CANCER IMAGING

Anticancer research, 2018-04, Vol.38 (4), p.2538

2018

Volltextzugriff (PDF)

TARC before ASCT Is Highly Predictive of Outcome in Patients with Relapsed or Refractory (R/R) Classical Hodgkin Lymphoma (cHL) after First-Line Therapy

Blood, 2016-12, Vol.128 (22), p.3009-3009

2016

Volltextzugriff (PDF)

Pretreatment Dosimetry in HCC Radioembolization with (90)Y Glass Microspheres Cannot Be Invalidated with a Bare Visual Evaluation of (99m)Tc-MAA Uptake of Colorectal Metastases Treated with Resin Microspheres

The Journal of nuclear medicine (1978), 2014-07, Vol.55 (7), p.1215-1216

2014

Volltextzugriff (PDF)

Pretransplantation [18‐F]fluorodeoxyglucose positron emission tomography scan predicts outcome in patients with recurrent Hodgkin lymphoma or aggressive non‐Hodgkin lymphoma undergoing reduced‐intensity conditioning followed by allogeneic stem cell transplantation

Cancer, 2010-11, Vol.116 (21), p.5001-5011

2010

Volltextzugriff (PDF)

1 – 25 von 155

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(125)
Mit Volltextzugriff
(133)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(79)
Life Sciences & Biomedicine
(77)
Humans
(69)
Female
(41)
Oncology
(37)
Middle Aged
(32)
Male
(31)
Adult
(27)
Biological And Medical Sciences
(25)
Medical Sciences
(25)
Aged
(20)
F]fdg Pet/ct
(18)
Animals
(16)
Radiopharmaceuticals
(14)
Fluorodeoxyglucose F18
(13)
Radiology, Nuclear Medicine & Medical Imaging
(13)
Breast Cancer
(12)
Chemotherapy
(12)
Positron Emission Tomography
(12)
Breast Neoplasms - Diagnostic Imaging
(11)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Sirolimus in Advanced Epithelioid Hemangioendothelioma: A Retrospective Case-Series Analysis from the Italian Rare Cancer Network Database

Pazopanib in advanced and platinum-resistant urothelial cancer: an open-label, single group, phase 2 trial

Response to Sunitinib Malate in Advanced Alveolar Soft Part Sarcoma

Neoadjuvant eribulin mesylate following anthracycline and taxane in triple negative breast cancer: Results from the HOPE study

Simple preparation and purification of ethanol-free solutions of 3′-deoxy-3′-[18 F]fluorothymidine by means of disposable solid-phase extraction cartridges

Staging and follow-up of high-grade malignant salivary gland tumours: The role of traditional versus functional imaging approaches – A review

Interim Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography for Early Metabolic Assessment of Therapeutic Response to Chemotherapy for Metastatic Transitional Cell Carcinoma

FDG-PET for axillary lymph node staging in primary breast cancer

Amino acid positron emission tomography to monitor chemotherapy response and predict seizure control and progression-free survival in WHO grade II gliomas

Cabozantinib (CABO) plus durvalumab (DURVA) in patients with advanced and chemotherapy-treated bladder carcinoma of urothelial and non-urothelial histology: An open-label, single-arm, phase 2 trial

F-FLT PET/CT as an imaging tool for early prediction of pathological response in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy: a pilot study

Role of pretreatment 18F-FDG PET/CT parameters in predicting outcome of non-endemic EBV DNA-related nasopharyngeal cancer (NPC) patients treated with IMRT and chemotherapy

Pazopanib in patients (pts) with advanced germ cell tumors (GCT): Results from an open-label, single-group, phase 2 trial (Pazotest-01)

Interim results from PURE-01: A phase 2, open-label study of neoadjuvant pembrolizumab (pembro) before radical cystectomy for muscle-invasive urothelial bladder carcinoma (MIUC)

Imatinib mesylate in chordoma

FDG-PET in thyroid cancer

Design of an open label, randomized, phase II study of paclitaxel and panitumumab compared to paclitaxel alone in patients with relapsed or refractory urothelial cancer

High efficiency preparation of L-[S-methyl-11C]methionine by on-column [11C]methylation on C18 Sep-Pak

Pan-HER tyrosine-kinase inhibitors (TKI) dacomitinib and afatinib in penile squamous cell carcinoma (PSCC): Results from an ongoing open-label, single-group, phase 2 trial of dacomitinib in chemonaive patients (pts)

Pazopanib (PZP) in germ cell tumors (GCT) after chemotherapy (CT) failure: Final results of the open label, single-group, phase II Pazotest trial

Nuclear medicine imaging in breast cancer: current strategies and future directions

IMMUNO-PET: A NEW TOOL FOR PROSTATE CANCER IMAGING

TARC before ASCT Is Highly Predictive of Outcome in Patients with Relapsed or Refractory (R/R) Classical Hodgkin Lymphoma (cHL) after First-Line Therapy

Pretreatment Dosimetry in HCC Radioembolization with (90)Y Glass Microspheres Cannot Be Invalidated with a Bare Visual Evaluation of (99m)Tc-MAA Uptake of Colorectal Metastases Treated with Resin Microspheres

Pretransplantation [18‐F]fluorodeoxyglucose positron emission tomography scan predicts outcome in patients with recurrent Hodgkin lymphoma or aggressive non‐Hodgkin lymphoma undergoing reduced‐intensity conditioning followed by allogeneic stem cell transplantation

Suchergebnisse filtern